NCT05706818

Validity and Reliability of the Community Integration Questionnaire-Revised in Lower Limb Amputees

Name: Clinical Trial NCT05706818
Creator: Hacettepe University
Keywords: Amputation, Validity and reliability study, other, clinical trial, Turkey

Validity and Reliability of the Turkish Version of the Community Integration Questionnaire-Revised (CIQ-R) in Lower Limb Amputees

Hacettepe University·ClinicalTrials.gov·otherCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Amputation
Drug/Device/Intervention: Validity and reliability study
Study type: Observational
Intervention type: other

Sponsor & location

Primary sponsor: Hacettepe University
Location: Ankara, Turkey

Timeline & enrollment

Phase: N/A
Start date: Nov 20, 2019
End date: Mar 27, 2022
Enrollment: 90 participants

Primary outcome

The Community Integration Questionnaire-Revised,The Community Integration Questionnaire-Revised,Trinity Amputation and Prosthesis Experience Scales,The Amputee Body Image Scale

Summary

The goal of this clinical trial is to determine the validity and reliability of the Community Integration Questionnaire-Revised (CIQ-R) scale in lower limb amputees. The main questions it aims to answer are:  - The Turkish version of the Community Integration Questionnaire-Revised is valid for lower extremity amputees.  - The Turkish version of the Community Integration Questionnaire-Revised is reliable for lower extremity amputees.  Participants will:  • Fill out general information, CIQ-R, TAPES, and ABIS forms.

ICD-10 classifications

Amputation of limb(s)Traumatic amputation of both feetTraumatic amputation of upper and lower limbs, any combination [any level]Traumatic amputations involving other combinations of body regionsTraumatic amputation of lower leg

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05706818
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT05706818 through Pure Global AI's free database. This phase not specified trial is sponsored by Hacettepe University and is currently Completed. The study focuses on Amputation. Target enrollment is 90 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.